Based on our current understanding of RELA/RELB signaling in promoting ovarian cancer proliferation and stem-cell phenotypes [4], the decreased expression of has-miR-452-5p when RELA or RELB are silenced across OV90, OVCAR8, and ACI23 cells suggests an oncogenic function. The gene discussed is RELB; the disease is ovarian cancer.